Ischemic stroke in a man using estrogen.

J Stroke Cerebrovasc Dis

Casey Eye Institute, and Oregon Stroke Center, Oregon Health & Science Center, Portland, OR 97201-4197, USA.

Published: October 2007

Ischemic cerebrovascular disease has been associated with oral contraceptives but not standard hormone replacement in women. It is unknown whether or not estrogen therapy in a male is associated with an increased risk of stroke. We report a single case of a genetic male taking high doses of estrogen and progesterone who suffered a stroke. A 46-year-old man was using high doses of estrogen and progesterone while awaiting surgical gender reassignment. He had suffered a deep venous thrombosis 1 year prior to presentation. He developed an acute left visual field cut, left neglect, and left hemiparesis. Neuroimaging disclosed a large right hemispheric stroke. A complete evaluation did not reveal an etiology. No identifiable cause could be found for this patient's stroke, except for his high-dose hormonal therapy. Physicians treating male-to-female transsexuals need to be aware of this rare complication of hormone therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1053/jscd.2002.126693DOI Listing

Publication Analysis

Top Keywords

high doses
8
doses estrogen
8
estrogen progesterone
8
ischemic stroke
4
stroke man
4
estrogen
4
man estrogen
4
estrogen ischemic
4
ischemic cerebrovascular
4
cerebrovascular disease
4

Similar Publications

Purpose: Reports of gene therapy-associated retinal atrophies and inflammation have highlighted the importance of preclinical safety assessments of adeno-associated virus (AAV) vector systems. We evaluated in nonhuman primates (NHPs) the ocular safety and toxicology of a novel AAV gene therapy targeting retinitis pigmentosa caused by mutations in PDE6A, which has since been used in a phase I/II clinical trial (NCT04611503).

Methods: A total of 34 healthy cynomolgus animals (Macaca fascicularis) were treated with subretinal injections of rAAV.

View Article and Find Full Text PDF

Background: Swallowed topical corticosteroids (STC) are an effective first-line therapy for patients with eosinophilic esophagitis (EoE), both for induction and maintenance of remission. All interventional trials with STC used twice-daily dosing regimens. However, in other inflammatory gastrointestinal disorders, corticosteroids are given once daily (OD) with equal outcomes and improved compliance.

View Article and Find Full Text PDF

Objectives: The objective was to compare the incidence of recovery agitation and efficacy of two different intravenous (IV) doses of ketamine (0.5 mg/kg vs. 1 mg/kg) in adult patients who presented to the emergency department (ED) requiring procedural sedation with ketamine.

View Article and Find Full Text PDF

Evaluation of the Effect of Virgin Rice Bran Oil (VRBO) on DoxorubicinInduced Cardiotoxicity in Wistar Rats.

Curr Cardiol Rev

January 2025

Department of Nutrition, Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.

Objective: The usage of doxorubicin (DOX), an antineoplastic drug that is frequently used for the cure of cancer, is restricted to maximal doses due to its cardiac toxicity. Reactive oxygen species produced by DOX result in lipid peroxidation and organ failure, ultimately resulting in cardiomyopathy. Due to its high polyphenol content, virgin rice bran oil (VRBO) is a diet nutritional supplement with a strong antioxidant.

View Article and Find Full Text PDF

Background: Poor acute postoperative pain control, coupled with the use of intravenous medications with a limited and unsafety efficacy spectrum, has led to new therapeutic alternative explorations to reduce adverse events while increasing its analgesic efficacy. There cannabinoids have been proposed as a useful control agent in post-surgical pain. Nevertheless, to date, there is no solid evidence to evaluate them.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!